Reuma.pt Projects
Research
Project Submission
Submit your Reuma.pt project on our platform. First, see the regulation of access, use and disclosure of Reuma.pt data here. Remember that if you don’t have an account, you will have to register. If you need any help, don’t hesitate to go to our FAQs page or get in touch with us.
Projects list
Select the status of the Reuma.pt projects
Approval date
Title
Language
- View Button
-
06-11-2023
Difficult-to-treat psoriatic arthritis
EN
View
-
17-03-2023
Long-term outcomes of juvenile idiopathic arthritis – the burden of the comorbidities
EN
View
-
05-06-2023
Juvenile idiopathic arthritis with chronic anterior uveitis – how does it evolve over time and into adulthood?
EN
View
-
09-05-2023
Clinical, laboratorial and immunological risk factors of VEDOSS progression to Systemic Sclerosis – a multicentric nationwide study
EN
View
-
11-04-2023
Characterization of disease activity and severity of patients with Systemic Lupus Erythematosus in Portugal: a cross-sectional national registry-based study
EN
View
-
07-03-2023
The use of ASDAS in patients with axial spondyloarthritis starting bDMARDs: A multicentre prospective cohort
EN
View
-
03-02-2023
PORTRESS — PORTuguese REgistry of Sjögren’s Syndrome
EN
View
-
14-12-2022
Axial involvement in Psoriatic Arthritis: a multicentric analysis
EN
View
-
13-10-2022
Effectiveness and safety of biologic disease-modifying antirheumatic therapy in Portuguese elderly patients with psoriatic arthritis – a multicenter retrospective cohort study with two years follow-up
EN
View
-
12-08-2022
The real impact of age on psoriatic disease: a portuguese multicenter study
EN
View
-
28-07-2022
Impact of comorbidity burden as scored using the rheumatic disease comorbidity index (RDCI) on response to treatment with the first biological agent among patients with Psoriatic Arthritis
EN
View
-
03-06-2022
How does age influence the clinical features of patients with giant cell arteritis?
EN
View
-
31-05-2022
Biologic disease-modifying antirheumatic drugs survival and safety in late-onset axial spondyloarthritis – data from a Portuguese registry
EN
View
-
03-05-2022
Determinants of quality of life in psoriatic arthritis – results from the Portuguese rheumatic diseases registry (Reuma.pt)
EN
View
-
03-05-2022
Characteristics of patients with late onset Axial Spondyloarthritis
EN
View
-
16-02-2022
Interstitial lung disease in primary Sjögren’s syndrome: the portrait of a national cohort
EN
View
-
21-04-2021
Lung involvement in rheumatoid arthritis: the portrait of a national cohort
EN
View
-
30-10-2020
Long-term predictors of quality of life in axial Spondyloarhritis
EN
View
-
20-10-2020
The burden of spondyloarthritis on patients’ work productivity in Portugal and a comparison with rheumatoid arthritis: across-sectional analysis using the Portuguese national registry Reuma.pt
EN
View
-
23-10-2019
Registro Brasil & Portugal de vasculites sistêmicas
PT
View
-
07-04-2019
PROSAS STUDY – Persistence, Effectiveness and Real-World Outcomes in SpondylArthritis patients treated with Secukinumab
EN
View
-
21-03-2019
PREDICT - Personalized therapy for RhEumatic DIseases via machine learning
EN
View
-
18-01-2019
Determinants of happiness and quality of life in people with systemic sclerosis: a structural equation modelling approach
EN
View
-
29-06-2018
Effectiveness, safety, quality of life, costs and persistence of biosimilar Etanercept compared to reference Etanercept in Juvenile Idiopathic Arthritis patients - data from the Portuguese register Reuma.pt
EN
View
-
17-06-2018
“PRO Reuma Initiative”: collecting patient-reported outcomes using touchscreen technology
EN
View
-
29-04-2018
Validation of Juvenile Spondyloarthritis Disease Activity Index (JSPADA) in a prospective cohort of Portuguese patients with juvenile spondyloarthritis
EN
View
-
25-04-2018
Autoinflammatory diseases: analysis based on the Rheumatic Diseases Portuguese Register
EN
View
-
18-03-2018
Predictors of skin score change in systemic sclerosis: a Reuma.pt analysis
EN
View
-
18-03-2018
Neoplasias e doenças reumáticas inflamatórias sistémicas
PT
View
-
07-07-2017
Pattern of drug use in systemic lupus erythematosus and reasons for drug discontinuation in real life clinical practice
EN
View
-
04-02-2017
Adult outcomes of juvenile idiopathic arthritis
EN
View
-
14-05-2015
Coorte portuguesa de artrite inicial
PT
View
-
25-03-2015
Biologics discontinuation in Rheumatoid Arthritis and Spondylarthritis Retrospective analysis of reasons for discontinuation and outcome
EN
View
-
27-01-2022
Comparative effectiveness and safety of switching to an alternative TNFi or a biologic with a different mode of action (MoA) in Psoriatic Arthritis patients after discontinuation of a first line TNFi: results from the Rheumatic Diseases Portuguese Register
EN
View
-
09-09-2021
Reuma.pt/myositis – the Portuguese registry of inflammatory myopathies
EN
View
-
09-09-2021
Assessment of calcinosis in Portuguese patients with Systemic Sclerosis – a multicenter study
EN
View
-
25-05-2021
Severe infections in Portuguese patients with Rheumatoid Arthritis under biologic treatment (SIPPRA-B Study)
EN
View
-
13-09-2020
Depression and anxiety disorders in Spondyloarthritis patients on biologic therapy registered in Reuma.pt: prevalence, role of disease-related factors and influence of biologic therapy
EN
View
-
08-08-2020
O uso de um índice de comorbilidades para prever a resposta clínica em doentes com artrite reumatoide tratados com o seu primeiro agente biológico
PT
View
-
20-07-2020
Effectiveness and safety of original and biosimilar etanercept (Enbrel vs Benepali) in bDMARD-naïve patients in a real-world cohort of Portugal
EN
View
-
10-07-2020
Demographic and clinical features of Portuguese Patients with Systemic Sclerosis: a Nationwide Multicenter Cohort Study
EN
View
-
14-06-2020
Clinical course and predictors of severe COVID-19 among patients with rheumatic diseases in Portugal – a multicentre, nationwide study
EN
View
-
05-03-2020
Há diferenças clínicas atribuíveis ao sexo nas espondilartrites axiais?
PT
View
-
10-10-2019
Frequency of disease-associated autoantibodies in Reuma.pt systemic sclerosis cohort patients and its association with characteristic clinical features
EN
View
-
19-11-2018
Demyelinating diseases in patients treated with tumor necrosis factor inhibitors for rheumatic diseases.
EN
View
-
14-11-2018
Early retirement attributed to Rheumatoid Arthritis and its predictors
EN
View
-
27-10-2018
Safety and effectiveness of biologic Disease-Modifying Antirheumatic Drugs in elderly patients with rheumatoid arthritis
EN
View
-
13-09-2018
Efficacy and Safety of Belimumab in the treatment of Systemic Lupus Erythematosus: a Prospective Multicenter Study
EN
View
-
10-09-2018
Remission and low disease activity matrix tool: results in real-world Rheumatoid Arthritis patients under anti-TNFα therapy
EN
View
-
15-08-2018
Predictive factors of relapse, in patients with JIA in remission, after discontinuation of synthetic disease-modifying antirheumatic drugs
EN
View
-
16-06-2018
Comparing disease features and outcomes in patients with membranous and proliferative lupus nephritis
EN
View
-
09-06-2018
Juvenile idiopathic arthritis in Portugal and Brazil: a comparative study
EN
View
-
08-06-2018
Impact of the implementation of biosimilars in the treatment of different rheumatic diseases perceived by the patients and by society (repercussion in Patient Reported Outcomes and economic costs)
EN
View
-
16-05-2018
Variation in patient-reported outcomes for patients with Inflammatory Rheumatic diseases: evidence from Portugal
EN
View
-
12-04-2018
Mapping from the Ankylosing Spondylitis Disease Activity Score (ASDAS) to EQ5D in patients with Axial Spondyloarthritis (axSpA)
EN
View
-
06-10-2017
Comparative long-term effectiveness and safety of switching to alternative tumour necrosis factor antagonists, tocilizumab or rituximab in patients with rheumatoid arthritis and inadequate response to a first-line TNF inhibitor
EN
View
-
10-08-2017
Interstitial lung disease in scleroderma patients
EN
View
-
19-06-2017
Biological therapy in women with immune-mediated inflammatory rheumatic diseases: influence on pregnancy outcomes
EN
View
-
19-04-2017
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
EN
View
-
19-01-2017
Efficacy and safety of biosimilar infliximab CT-P13 compared to originator infliximab in rheumatoid arthritis and axial spondyloarthritis patients
EN
View
-
29-09-2016
Avaliação da efetividade e segurança dos agentes biológicos nos doentes Portugueses com artrites idiopáticas juvenis
PT
View
-
15-09-2016
Eligibility criteria for TNFi therapy in axSpA: BASDAI vs ASDAS
EN
View
-
02-06-2016
Real world effectiveness of switching between tumor necrosis factor inhibitors (TNFi) in Psoriatic Arthritis – EXCHANGE PsA
EN
View
-
02-02-2016
RAID - The potential role of the "Rheumatoid Arthritis Impact of Disease" score in the management of RA
EN
View
-
03-12-2015
EARLY PsA – Effectiveness of early Adalimumab therapy in psoriatic arthritis patients from Reuma.pt, the Rheumatic Diseases Portuguese Register, Portuguese RheumatoLogy SocietY (SPR)
EN
View
-
27-08-2015
Drug survival analysis of biologic agents in rheumatoid arthritis and predictors of drug discontinuation in real world clinical practice
EN
View
-
28-02-2015
GO-REAL - Real-life effectiveness of golimumab in biologic-naïve patients with rheumatoid arthritis – data from Reuma.pt, a Portuguese registry
EN
View
-
23-01-2015
Reuma.pt/ Vasculitis: The Portuguese Vasculitis Register
EN
View
-
23-11-2014
Predictors of response to TNF-α blockers in patients with polyarticular psoriatic arthritis
EN
View
-
16-06-2014
Disease course and adult outcomes of childhood-onset rheumatic diseases
EN
View
-
06-04-2014
Tuberculosis risk and prevention in rheumatic patients treated with biological therapy
EN
View
-
25-01-2014
Lupus eritematoso sistémico em Portugal: Caracterização de subpopulações com início precoce e tardio de doença
PT
View
-
07-01-2014
Project T2T Portugal: T2T Monitor
EN
View
-
03-01-2014
Drug survival and predictive factors for retention of TNF-α blockers in patients with ankylosing spondylitis: results from Reuma.pt
EN
View
-
09-07-2013
Avaliação de dano e a sua associação a factores clínicos e laboratoriais de doentes com Lupus eritematoso sistémico em Portugal
PT
View
-
12-02-2013
Comparação da Sensibilidade dos Critérios de Classificação ACR 1997 e SLICC 2012 para LES
PT
View
-
14-10-2012
A Realidade da Artrite Idiopática Juvenil em Portugal
PT
View
-
09-03-2011
A national genome wide association study to predict the response to treatment in rheumatoid arthritis patients
EN
View